Ambani OrgoChem Ltd (AMBANIORGO) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Ambani OrgoChem Ltd on NSE and BSE, with an AI summary of each filing.
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding a press release dated November 02, 2026, titled "Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 30(6) and Sub-para 3 of Para A of Part A of Schedule III thereto Revision in Credit Rating(s) of Bank Loan Facilities".
Press Release · 03 Nov 2026, 1:56 am
Ambani Orgochem Bank Loan Ratings Upgraded by Infomerics Infomerics upgraded Ambani Orgochem Limited’s bank loan facilities, removing them from the "Issuer Not Cooperating" category on 2nd Nov'26. The long-term rating was raised from IVR BB/Negative to IVR BBB-/Stable, while the short-term rating improved from IVR A4 to IVR A3 on enhanced facilities of ₹116.72 crore (up from ₹100.86 crore). The upgrade reflects an improving financial profile, with H1FY27 PAT surging YoY to ₹3.41 crore from ₹0.20 crore, alongside operational recovery at its Dahej plant and capital infusion from preferential issues.
AMBANI ORGOCHEM LIMITED has informed the Exchange about Transcript of Earnings Conference Call held on 27th October, 2026.
Transcript · 01 Nov 2026, 12:44 am
Ambani Orgochem H1 FY27 Earnings Call Summary Ambani Orgochem reported strong H1 FY27 results, with revenue rising 54.87% YoY to ₹171.22 crore, EBITDA increasing 43% YoY to ₹11.32 crore, and net profit surging to ₹3.45 crore from ₹19.07 lakh in H1 FY26. Operating cash flow turned positive to ₹1.84 crore. The Tarapur plant is operating at 100%+ utilization, prompting a capacity expansion from 2,000 to 4,500 tons per month by Q4 FY27 for ₹15–20 crore. Management expects Dahej expansion completion in FY28, with H2 FY27 performance guided to exceed H1.
AMBANI ORGOCHEM LIMITED has informed the Exchange about Resignation of Director/KMP/SMP
Change in Management · 30 Oct 2026, 1:28 am
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding Resignation of Mr Bhavin Jitendra Patel as Non- Executive Non-Independent Director of the company w.e.f. October 29, 2026.
Change in Management · 30 Oct 2026, 1:27 am
Ambani Orgochem Director Bhavin Patel Resigns Effective 29th Oct'26 Ambani Orgochem Limited announced that Mr. Bhavin Jitendra Patel has resigned from his position as Non-Executive Non-Independent Director of the company, effective from the close of business hours on 29th Oct'26. According to the regulatory disclosure under SEBI LODR Regulations, the resignation was tendered due to his other professional priorities and commitments.
AMBANI ORGOCHEM LIMITED has informed the Exchange about Link of Recording
Audio / Video · 28 Oct 2026, 5:14 pm
Ambani Orgochem Submits Audio/Video Link for H1 FY27 Earnings Call Ambani Orgochem Limited has submitted the audio/video recording link for its earnings conference call held on 27th Oct'26 at 4:00 PM. The call discussed the company's standalone and consolidated unaudited financial results for the half year ended 30th Sep'26. The recording has been made available on the company's website and via Google Drive in compliance with SEBI LODR Regulations, with the company confirming no unpublished price-sensitive information was shared.
AMBANI ORGOCHEM LIMITED has informed the Exchange about issue of up to 43,92,500 (Forty-Three Lakhs Ninety-Two Thousand Five Hundred) Convertible Warrants, each convertible into one Equity Share of Rs. 10/- each, at an issue price of Rs. 100/- per Warrant (including a premium of Rs. 90/-), aggregating up to Rs. 43,92,50,000/-, to 9 (Nine) Proposed Allottees belonging to the Promoter / Promoter Group and Non-Promoter (Public) categories, subject to the in-principle approval of the Exchange.
Others (Uncategorized) · 28 Oct 2026, 12:33 am
Ambani Orgochem Approves Preferential Issue of Convertible Warrants Worth Rs 43.93 Crore Ambani Orgochem Limited's members approved issuing up to 43,92,500 convertible warrants at Rs. 100 each (face value Rs. 10, premium Rs. 90) on a preferential basis, aggregating up to Rs. 43.925 cr across nine promoter and public allottees on 26th Oct'26. Terms require 25% upfront consideration, with the remaining 75% payable upon conversion within 18 months. Members also approved reclassifying authorized share capital into 2.00 cr equity shares of Rs. 10 each, maintaining total authorized capital at Rs. 20.00 cr, and adopting new Articles of Association.
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding the Amendment to AOA/MOA of the company.
Others (Uncategorized) · 28 Oct 2026, 12:30 am
Ambani Orgochem Approves ₹43.93 Crore Preferential Convertible Warrants Issue and Capital Reclassification Ambani Orgochem Limited's members approved a preferential issue of up to 43,92,500 convertible warrants at ₹100 each (including a ₹90 premium), raising up to ₹43.93 crore across nine promoter and public allottees on 26th Oct'26. Terms require 25% upfront and the remaining 75% payable upon conversion within 18 months. Key promoter Rakesh Shah's holding will rise from 48.94% to 55.33% post-conversion. Shareholders also approved reclassifying authorized capital to 2.0 crore equity shares of ₹10 each (₹20 crore) alongside adopting updated Articles of Association.
AMBANI ORGOCHEM LIMITED has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on October 26, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 27 Oct 2026, 11:05 pm
Ambani Orgochem Shareholders Approve Preferential Warrants and Capital Alterations Unanimously Ambani Orgochem Limited announced that shareholders approved all four special resolutions at its Extra-Ordinary General Meeting held on 26th Oct'26. With 100% of the 56,73,559 valid votes cast in favor via remote e-voting, the company secured approval for reclassifying authorized share capital, altering the capital clause of the Memorandum of Association, issuing convertible warrants on a preferential basis, and adopting Table F of Schedule I of the Companies Act, 2013, as Articles of Association. No votes were cast against or declared invalid.
AMBANI ORGOCHEM LIMITED has informed the Exchange about Investor Presentation for H1 FY-27 under Regulation 30 read with Para A of Schedule III ofthe SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Investor Presentation · 27 Oct 2026, 1:12 am
Ambani Orgochem Delivers Robust H1 FY27 Performance Alongside Strategic Expansions Ambani Orgochem Limited reported strong consolidated H1 FY27 results on 26th Oct'26, with total income from operations surging 54.87% YoY to ₹171.22 crore. EBITDA increased 43.00% YoY to ₹11.32 crore, while net profit grew exponentially to ₹3.45 crore, driving EPS up 1,514.46% YoY to ₹4.02. Growth is supported by ongoing capacity expansions, including scaling acrylic coatings and adhesives capacity from ~2,000 to ~4,500 T/month at Tarapur, and expanding salicylic acid capacity from ~50 to ~200 T/month.
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on October 26, 2026
Annual General Meeting · 27 Oct 2026, 12:48 am
Ambani Orgochem Concludes EOGM on Capital Reclassification and Preferential Warrant Issue Ambani Orgochem Limited conducted its 1st Extra-Ordinary General Meeting for FY26-27 on 26th Oct'26 via video conferencing. Key special resolutions presented for member approval included the reclassification of authorised share capital, alteration of the capital clause in the Memorandum of Association, issuance of convertible warrants on a preferential basis, and the adoption of Table F of Schedule I of the Companies Act, 2013 as Articles of Association. Consolidated voting results and the Scrutinizer’s report will be declared within two working days and submitted to NSE.
AMBANI ORGOCHEM LIMITED has informed the Exchange about Schedule of meet
Intimation · 27 Oct 2026, 4:00 pm
Ambani Orgochem Schedules H1 FY27 Earnings Call on 27th Oct'26 Ambani Orgochem Limited has scheduled an earnings conference call on 27th Oct'26 at 04:00 PM IST to discuss its unaudited standalone and consolidated financial results for the half year ended 30th Sep'26 (H1 FY27). The call will feature key management personnel, including Managing Director Rakesh H. Shah, Chief Executive Officer Paresh Shah, and Strategy Director Aashay Shah.
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding Corrigendum to Notice of Extra Ordinary General Meeting to be held on October 26, 2026
Annual General Meeting · 17 Oct 2026, 1:12 am
Ambani Orgochem Revises Preferential Issue Size Downward to Rs 43.93 Crore Ambani Orgochem Limited issued a corrigendum to its EGM notice for the meeting on 26th Oct'26, reducing its proposed preferential convertible warrant issue after dropping an allotment of 2,500 warrants to one investor. The issue size is revised down to 43,92,500 warrants across nine allottees, aggregating up to Rs 43.93 cr at an issue price of Rs 100 per warrant (floor price: Rs 61.13). Proceeds will fund working capital (Rs 20.00 cr), business expansion/premises acquisition (Rs 13.00 cr), and general corporate purposes (Rs 10.93 cr).
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding Outcome of Board Meeting held on October 16, 2026.
Outcome · 16 Oct 2026, 11:35 pm
Ambani Orgochem Trims Preferential Warrant Issue Size to Rs 43.93 Crore Ambani Orgochem Limited’s board approved reducing its proposed preferential issue of convertible warrants from 43,95,000 to 43,92,500 warrants, lowering the total fundraising target from Rs 43.95 cr to Rs 43.93 cr. The revision follows the exclusion of 2,500 warrants previously proposed for allotment to Ms. Bhavna Girikrishna Maniar, decreasing the number of allottees to nine. The issue price remains unchanged at Rs 100 per warrant. Consequently, post-issue fully diluted equity capital is revised to 1,33,11,159 shares, with an EGM corrigendum to be issued accordingly.
Quarterly Compliance 27(2) Ambani Orgochem Limited :- Non-Applicability of Regulation 27(2) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015
Others (Uncategorized) · 16 Oct 2026, 2:02 am
Ambani Orgochem Confirms Non-Applicability of SEBI Corporate Governance Reporting for Q2'27 Ambani Orgochem Limited informed the NSE that Corporate Governance reporting under Regulation 27(2) of SEBI (LODR) Regulations, 2015, does not apply to the company for the quarter ended 30th Sep'26. Under Regulation 15(2), entities listed on SME platforms are exempt from the compliance provisions specified in Regulations 17 to 27. Consequently, as an NSE SME Platform-listed entity, the company is exempt from submitting the quarterly Corporate Governance Report.
AMBANI ORGOCHEM LIMITED has submitted to the Exchange, the unaudited financial results for the period ended September 30, 2026.
Financial Result · 16 Oct 2026, 1:01 am
Ambani Orgochem Reports Strong H1 Performance with Net Profit Surging to ₹345 Lakhs Ambani Orgochem Limited reported a 54.87% YoY increase in total consolidated income to ₹17,122.12 lakhs for the half year ended 30th Sep'26, compared to ₹11,055.94 lakhs in the corresponding period ended 30th Sep'25. Consolidated net profit rose sharply to ₹345.04 lakhs from ₹19.07 lakhs YoY, lifting basic EPS to ₹4.02 from ₹0.249. During the period, the company converted 12,60,000 warrants raising ₹850.50 lakhs, redeemed ₹455.23 lakhs of preference shares, and recognized an assessed insurance claim receivable of ₹817.87 lakhs for business interruption loss.
This is with reference to NSE query dated October 13, 2026 with respect to filing the SDD Certificate for the period from 01.04.2026 to till date.Therefore, we herewith enclose a Certificate provided by M/s. Mayank Arora & Co. (Practicing Company Secretary Firm) under Regulation 3(5) and 3(6) of SEBI (Prohibition of Insider Trading) Regulations, 2015 for the period from 01.04.2026 to till date of our Company.You are requested to take note of the same.
Others (Uncategorized) · 16 Oct 2026, 12:17 am
Ambani Orgochem Submits Full SEBI PIT Structured Digital Database Compliance Certificate Ambani Orgochem Limited submitted its Structured Digital Database (SDD) compliance certificate for 1st Apr'26 to 15th Oct'26, responding to an NSE query dated 13th Oct'26. Issued by Practicing Company Secretary firm Mayank Arora & Co. under Regulations 3(5) and 3(6) of SEBI PIT Regulations, 2015, the certificate confirms an internal, non-tamperable SDD with access controls and an audit trail. The company captured all 8 required UPSI events during the period, with zero non-compliances reported for the previous financial year.
AMBANI ORGOCHEM LIMITED has informed the Exchange about Board Meeting to be held on 15-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 15 Oct 2026, 5:30 am
Ambani Orgochem Board to Consider Half-Yearly Financial Results on 15th Oct'26 Ambani Orgochem Limited has informed the stock exchange that its Board of Directors is scheduled to meet on 15th Oct'26. The board will inter-alia consider and approve the un-audited financial results of the company for the half-year ended Sep'26.
To consider and approve the unaudited financial results for the period ended September 30, 2026.
Intimation · 15 Oct 2026, 5:30 am
Ambani Orgochem Board to Consider Half-Year Financial Results on Oct 15'26 Ambani Orgochem Limited announced that its Board of Directors will meet on 15th Oct'26 to consider and approve the standalone and consolidated unaudited financial results, along with the Limited Review Report, for the half year ended 30th Sep'26. Additionally, the company confirmed that the trading window for dealing in its securities by designated persons has been closed since 1st Oct'26 and will remain closed until 48 hours after the public declaration of the financial results.
AMBANI ORGOCHEM LIMITED has informed the Exchange that Record date for the purpose of Meeting is 19-Oct-2026.
Others · 04 Oct 2026, 2:48 am
Ambani Orgochem Clarifies EGM Cut-Off Date and Book Closure Ambani Orgochem Limited has issued a revised intimation clarifying that it will not close its Register of Members and Share Transfer Books for the Extra-Ordinary General Meeting (EGM) scheduled for 26th Oct'26. The Board has fixed 19th Oct'26 as the single cut-off date to determine member eligibility for remote e-voting and voting at the EGM, superseding its earlier notice.
AMBANI ORGOCHEM LIMITED has informed the Exchange that Record date for the purpose of Meeting is 19-Oct-2026.
Others · 04 Oct 2026, 2:28 am
Ambani Orgochem Announces AGM Cut-Off Date and Book Closure Schedule Ambani Orgochem Limited has scheduled the cut-off date as 19th Oct'26 to determine member eligibility and entitlement for its 40th Annual General Meeting. Consequently, the register of members and share transfer books will remain closed from 20th Oct'26 to 26th Oct'26 (both days inclusive) in compliance with Regulation 42 of SEBI LODR Regulations, 2015.
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on October 26, 2026
Annual General Meeting · 04 Oct 2026, 1:56 am
Ambani Orgochem Proposes Rs. 43.95 Crore Preferential Issue of Warrants Ambani Orgochem Limited has scheduled an EGM on 26th Oct'26 to approve raising up to Rs. 43.95 crore via a preferential issuance of up to 43,95,000 convertible share warrants at Rs. 100 per warrant (FV Rs. 10, premium Rs. 90) to promoters and public entities. This includes 30,00,000 warrants to promoter Rakesh Hasmukhlal Shah, increasing promoter holding from 52.59% to 57.84% post-dilution. Proceeds will fund working capital and expansion. Additionally, the company seeks to reclassify unissued preference shares into equity, expanding authorized equity capital to Rs. 20 crore.
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding Appointment of Mr Rajesh Vasudeo Desai as Non- Executive Independent Director of the company w.e.f. September 26, 2026.
Change in Management · 29 Sept 2026, 8:33 pm
Ambani Orgochem Approves Board Appointments at 40th AGM At its 40th Annual General Meeting held on 26th Sep'26, Ambani Orgochem Limited approved key board appointments. Shareholders cleared the regularisation of Rajesh Vasudeo Desai, former Executive Director and Global CFO of Glenmark Pharmaceuticals, as Non-Executive Independent Director for a 5-year term. Additionally, Mahesh Shrirang Jagdale was regularised as an Independent Director for a 5-year tenure. The re-appointment of Bhavin Jitendra Patel, who retired by rotation, was also approved. None of the appointed directors hold equity shares in the company.
AMBANI ORGOCHEM LIMITED has submitted the Exchange a copy Srutinizers report of undefined held on September 26, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 29 Sept 2026, 1:41 am
Ambani Orgochem Shareholders Approve All Resolutions at 40th AGM Ambani Orgochem Limited announced that shareholders approved all eight resolutions with 100% majority at its 40th AGM held on 26th Sep'26. Passed ordinary business included the adoption of standalone and consolidated FY26 audited financial statements and the reappointment of director Bhavin Patel. Special business approved regularizing Rajesh Vasudeo Desai and Mahesh Shrirang Jagdale as Independent Directors for five-year terms, appointing the cost auditor for FY27, and hiking remuneration for Managing Director Rakesh Hasmukhlal Shah and Whole-Time Director Apooni Rakesh Shah, excluding related-party votes.
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding Outcome of Board Meeting held on September 28, 2026.
Outcome · 29 Sept 2026, 1:33 am
Ambani Orgochem Approves Preferential Issue of 4.395 Million Convertible Warrants The Board of Ambani Orgochem approved a preferential issuance of up to 43,95,000 warrants convertible into equal equity shares (face value Rs. 10 each) across 10 proposed allottees, exercisable within 18 months from allotment. Key allottees include promoter Rakesh Harsukhlal Shah (30,00,000 warrants, increasing stake to 55.32% from 48.94% post-conversion) and MNS Securities (10,00,000 warrants, raising holding to 12.77%). The board also approved adopting Table F Articles of Association, subject to shareholder approval at the EGM scheduled for 26th Oct'26.
AMBANI ORGOCHEM LIMITED has informed the Exchange regarding Proceedings of Annual General Meeting held on September 26, 2026
Annual General Meeting · 26 Sept 2026, 10:36 pm